LLY

The rise of cash-pay GLP-1 prescriptions, fueled by programs like LillyDirect, is generating plenty of buzz—but JPMorgan analyst Lisa C....

It's hard to argue with the kinds of results Eli Lilly (LLY 1.71%) has produced over the past five years....

If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not,...

Investors should never ignore valuations when picking stocks. The price a stock trades at can drastically impact your overall returns.

Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in...

Eli Lilly (NYSE: LLY) fourth-quarter performance exceeded the street expectations, with the company delivering adjusted earnings of $5.32 per share...

Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli...

Though Eli Lilly stock looks quite expensive, we suggest investors hold on to it as it still has robust growth...

Eli Lilly (LLY -0.27%) and Novo Nordisk (NVO 2.04%) are two of the most valuable healthcare stocks in the world,...

Pharmaceutical stocks represent an interesting prospect — while it is incredibly tough to separate the wheat from the chaff, picking...